Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple paracrine and autocrine signaling pathways refer to a collection of cell communication mechanisms rather than a single molecular entity. Paracrine signaling involves cells releasing ligands that diffuse short distances to act on nearby neighboring cells, often through pathways like receptor tyrosine kinase (RTK), JAK-STAT, Hedgehog, Wnt, and TGF-β, eliciting rapid, localized responses such as synaptic transmission or tissue patterning. Autocrine signaling occurs when a cell produces signals that bind to its own receptors, promoting self-regulation like in early embryonic development or immune cell activation via cytokines. These pathways regulate essential processes including cell proliferation, differentiation, wound healing, and angiogenesis but are not discrete therapeutic targets like specific receptors or enzymes. Dysregulation contributes to diseases, notably cancer where paracrine loops foster tumor microenvironments and metastasis, or inflammation through cytokine feedback. No drugs directly target "multiple paracrine and autocrine signaling pathways" as a unified entity; instead, specific components (e.g., VEGF inhibitors for angiogenesis) are modulated. This broad categorization lacks the specificity of validated druggable targets such as individual growth factor receptors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple paracrine and autocrine signaling pathways.